NCF1 (Neutrophil cytosol factor 1) variants and mutations
NCF1 (also known as Neutrophil cytosol factor 1) is a human protein-coding gene encoding a neutrophil cytosol factor 1 protein. After phagocyte activation, it joins the NADPH oxidase complex to generate microbicidal reactive oxygen species. Biallelic loss-of-function variants cause chronic granulomatous disease with recurrent bacterial and fungal infections. This analysis covers 611 NCF1 variants and mutations. Of these, 98% have computational variant effect predictions. Disease context includes chronic granulomatous disease, atrial fibrillation, and neurodegenerative disease. Example NCF1 variants include G2R, R7H, and A10T.
Variant analysis overview
- Gene: NCF1
- Protein: Neutrophil cytosol factor 1
- UniProt accession: P14598
- Organism: Homo sapiens
- Variants analyzed: 611
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 382 unspecified-consequence records; 128 missense variants; 63 synonymous variants; 17 frameshift variants; 5 splice-region variants; 7 stop-gained variants; 1 in-frame insertions; 6 in-frame deletions; 2 substitution
- Prediction scores: 598 variants have prediction scores (98% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: chronic granulomatous disease, atrial fibrillation, neurodegenerative disease, Rare familial disorder with hypertrophic cardiomyopathy, hypertrophic cardiomyopathy 4, Increased blood pressure, hypertensive disorder, cardiovascular disorder, Abnormality of the skeletal system, type 2 diabetes mellitus, autoimmune disease, connective tissue disorder.
Protein structure and variant hotspots
- Protein features: 3 domains; 6 post-translational modification sites.
- Structural context: 451 variants have structural context.
- PTM context: 4 variants overlap post-translational modification sites.
- Experimental data: 66 protein positions have experimental scores. Source: NCF1 SH3 domain domainome 1.0.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable NCF1 variants
Examples include G2R, R7H, A10T, A10D, A10G, L11L, R17C, R17H. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- G2R (p.Gly2Arg), gnomAD 7-74774035-G-A, REVEL 0.20, MetaLR 0.28
- R7H (p.Arg7His), Ensembl rs1554412875, REVEL 0.58, MetaLR 0.51
- A10T (p.Ala10Thr), rs587662134, gnomAD 7-74778319-G-A, CADD 0.78, SIFT 0.15
- A10D (p.Ala10Asp), gnomAD 7-74778320-C-A, CADD 2.02, SIFT 0.08
- A10G (p.Ala10Gly), gnomAD 7-74778320-C-G, CADD 2.81, SIFT 0.39
- L11L (p.Leu11Leu), gnomAD 7-74774064-G-T, CADD 9.72
- R17C (p.Arg17Cys), gnomAD 7-74774080-C-T, REVEL 0.41, MetaLR 0.29
- R17H (p.Arg17His), gnomAD 7-74774081-G-A, REVEL 0.49, MetaLR 0.33
- F18F (p.Phe18Phe), gnomAD 7-74774085-C-T, CADD 10.40
- V19I (p.Val19Ile), gnomAD 7-74774086-G-A, REVEL 0.03, MetaLR 0.06
- P20A (p.Pro20Ala), rs1796511368, gnomAD 7-74778328-C-G, CADD 3.14, SIFT 0.04
- P20T (p.Pro20Thr), gnomAD 7-74778328-C-A, CADD 3.96, SIFT 0.02
- P20L (p.Pro20Leu), rs1796511420, gnomAD 7-74778329-C-T, CADD 4.92, SIFT 0.00
- V25A (p.Val25Ala), gnomAD rs1554413122, REVEL 0.31, MetaLR 0.47
- V25L (p.Val25Leu), ExAC rs782272331, gnomAD rs782272331, REVEL 0.24, MetaLR 0.49
- V25M (p.Val25Met), gnomAD 7-74777267-G-A, REVEL 0.28, MetaLR 0.56
- V25V (p.Val25Val), rs782408014, gnomAD 7-74777269-G-A, CADD 10.70
- Y26H (p.Tyr26His), rs4029402, gnomAD 7-74777266-GGT-G, CADD 35.00
- M27T (p.Met27Thr), ExAC rs782052125, TOPMed rs782052125, gnomAD rs782052125, REVEL 0.36, MetaLR 0.46
- M27V (p.Met27Val), ExAC rs782039216, gnomAD rs782039216, REVEL 0.22, MetaLR 0.30
- F28F (p.Phe28Phe), rs782732294, gnomAD 7-74777278-C-T, CADD 12.50
- L29V (p.Leu29Val), gnomAD rs1554413126, REVEL 0.11, MetaLR 0.23
- L29R (p.Leu29Arg), gnomAD 7-74777280-T-G, REVEL 0.23, MetaLR 0.35
- V30G (p.Val30Gly), gnomAD 7-74777283-T-G, REVEL 0.90, MetaLR 0.66
- V30V (p.Val30Val), gnomAD 7-74777284-G-A, CADD 11.80
- K31Q (p.Lys31Gln), gnomAD 7-74777285-A-C, REVEL 0.30, MetaLR 0.50
- W32R (p.Trp32Arg), gnomAD 7-74777288-T-C, REVEL 0.72, MetaLR 0.50
- W32* (p.Trp32Ter), gnomAD 7-74777289-G-A, CADD 36.00
- W32L (p.Trp32Leu), gnomAD 7-74778350-G-T, CADD 4.63, SIFT 0.41
- Q33* (p.Gln33Ter), TOPMed rs1796487295
- Q33K (p.Gln33Lys), gnomAD 7-74778355-C-A, CADD 3.10, SIFT 0.78
- Q33R (p.Gln33Arg), gnomAD 7-74778356-A-G, CADD 4.87, SIFT 0.81
- Q33H (p.Gln33His), rs587598401, gnomAD 7-74778375-G-C, CADD 3.51, SIFT 0.12
- Q33Q (p.Gln33Gln), rs1195263560, gnomAD 7-74778399-G-A, CADD 16.20
- D34G (p.Asp34Gly), ExAC rs781959708, TOPMed rs781959708, gnomAD rs781959708, REVEL 0.71, MetaLR 0.49
- D34Y (p.Asp34Tyr), gnomAD 7-74777294-G-T, REVEL 0.86, MetaLR 0.57
- D34D (p.Asp34Asp), gnomAD 7-74777296-C-T, CADD 11.70
- L35L (p.Leu35Leu), rs375851395, gnomAD 7-74777297-C-T, CADD 11.50
- L35M (p.Leu35Met), gnomAD 7-74777297-C-A, REVEL 0.16, MetaLR 0.45
- L35V (p.Leu35Val), rs1796511300, gnomAD 7-74778325-T-G, CADD 4.82, SIFT 0.78
- L35S (p.Leu35Ser), gnomAD 7-74778326-T-C, CADD 5.66, SIFT 0.00
- L35R (p.Leu35Arg), rs1398655666, gnomAD 7-74778335-T-G, CADD 5.81, SIFT 0.00
- S36* (p.Ser36Ter), TOPMed rs1554413130, gnomAD rs1554413130, CADD 35.00
- S36L (p.Ser36Leu), rs1554413130, NCI-TCGA Cosmic COSV9919, TOPMed rs1554413130, gnomAD rs1554413130, REVEL 0.50, MetaLR 0.60, Variant assessed as somatic; moderate impact.
- S36W (p.Ser36Trp), NCI-TCGA Cosmic COSV9919, Variant assessed as somatic; moderate impact.
- S36S (p.Ser36Ser), rs146173318, gnomAD 7-74777302-G-A, CADD 1.81
- S36C (p.Ser36Cys), rs1554413265, gnomAD 7-74778341-C-G, CADD 2.99, SIFT 0.10
- S36F (p.Ser36Phe), rs1554413265, gnomAD 7-74778341-C-T, CADD 3.16, SIFT 0.10
- S36P (p.Ser36Pro), gnomAD 7-74778346-T-C, CADD 7.55, SIFT 0.33
- E37G (p.Glu37Gly), Ensembl rs1584369063, MetaLR 0.49, MetaSVM 0.11
- p.Glu37 Lys38insPheLeu, gnomAD 7-74777304-A-AGTT, CADD 18.80
- E37E (p.Glu37Glu), gnomAD 7-74777305-G-A, CADD 10.80
- K38F (p.Lys38Phe), gnomAD 7-74777304-A-AGTT, CADD 27.90
- p.Lys38 Val39delinsMet, gnomAD 7-74777306-AAGG-A, CADD 18.30
- K38M (p.Lys38Met), gnomAD 7-74777307-A-T, REVEL 0.38, MetaLR 0.50
- K38N (p.Lys38Asn), rs1554413133, gnomAD 7-74777307-AGG-A, CADD 26.40
- V39G (p.Val39Gly), Ensembl rs1584369077, REVEL 0.46, MetaLR 0.51
- V39L (p.Val39Leu), ExAC rs782544408, gnomAD rs782544408, REVEL 0.10, MetaLR 0.11
- V39M (p.Val39Met), ExAC rs782544408, gnomAD rs782544408, REVEL 0.22, MetaLR 0.47
- V39S (p.Val39Ser), rs1796511585, gnomAD 7-74778335-TG-T, CADD 1.24
- V39F (p.Val39Phe), gnomAD 7-74778337-G-T, CADD 1.51, SIFT 0.01
- V39D (p.Val39Asp), rs1563002381, gnomAD 7-74778338-T-A, CADD 5.51, SIFT 0.00
- V39V (p.Val39Val), rs1796511710, gnomAD 7-74778339-C-G, CADD 3.26
- V40G (p.Val40Gly), Ensembl rs1584369082, MetaLR 0.62, MetaSVM 0.40
- V40I (p.Val40Ile), Ensembl rs1796487970, REVEL 0.10, MetaLR 0.13
- V40del (p.Val40del), gnomAD 7-74777307-AGGT-A, CADD 18.90
- V40S (p.Val40Ser), gnomAD 7-74777310-TG-T, CADD 24.10
- V40L (p.Val40Leu), rs1554413134, gnomAD 7-74777311-GGT-G, CADD 28.80
- V40V (p.Val40Val), rs1554413136, gnomAD 7-74777314-C-T, CADD 5.75
- V40M (p.Val40Met), rs1314044604, gnomAD 7-74778358-G-A, CADD 1.40, SIFT 0.09
- V40A (p.Val40Ala), gnomAD 7-74778359-T-C, CADD 4.08, SIFT 0.40
- Y41S (p.Tyr41Ser), gnomAD rs1554413137, REVEL 0.56, MetaLR 0.54
- Y41del (p.Tyr41del), gnomAD 7-74777313-TCTA-T, CADD 19.00
- Y41H (p.Tyr41His), gnomAD 7-74777315-T-C, REVEL 0.52, MetaLR 0.58
- Y41C (p.Tyr41Cys), gnomAD 7-74777316-A-G, REVEL 0.48, MetaLR 0.56
- Y41Y (p.Tyr41Tyr), gnomAD 7-74777317-C-T, CADD 9.94
- R42Q (p.Arg42Gln), rs119103270, ClinGen CA115440, ClinVar RCV000002339, ClinVar RCV001557272, REVEL 0.82, MetaLR 0.79, Pathogenic, Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type
- R42W (p.Arg42Trp), rs782800778, ClinGen CA4298023, ClinVar RCV000788442, ClinVar RCV001283823, REVEL 0.82, MetaLR 0.77, Pathogenic, not provided
- R42G (p.Arg42Gly), rs1554413138, gnomAD 7-74777316-AC-A, CADD 24.90
- R42M (p.Arg42Met), gnomAD 7-74778332-G-T, CADD 3.24, SIFT 0.06
- R42K (p.Arg42Lys), gnomAD 7-74778332-G-A, CADD 3.62, SIFT 0.75
- R43C (p.Arg43Cys), ExAC rs781786929, gnomAD rs781786929, REVEL 0.32, MetaLR 0.62
- R43H (p.Arg43His), rs1554413140, gnomAD rs1554413140, REVEL 0.34, MetaLR 0.63, Variant assessed as somatic; moderate impact.
- R43D (p.Arg43Asp), gnomAD 7-74777320-G-GGA, CADD 22.80
- R43P (p.Arg43Pro), gnomAD 7-74777321-CGCTT-, CADD 29.50
- R43G (p.Arg43Gly), gnomAD 7-74777321-C-G, REVEL 0.42, MetaLR 0.54
- F44L (p.Phe44Leu), Ensembl rs2131600745, REVEL 0.52, MetaLR 0.18
- F44H (p.Phe44His), rs1554413144, gnomAD 7-74777323-CTT-C, CADD 26.80
- F44I (p.Phe44Ile), gnomAD 7-74777324-T-A, REVEL 0.75, MetaLR 0.42
- F44V (p.Phe44Val), gnomAD 7-74777324-T-G, REVEL 0.77, MetaLR 0.40
- F44S (p.Phe44Ser), gnomAD 7-74777325-T-C, REVEL 0.71, MetaLR 0.50
- T45S (p.Thr45Ser), TOPMed rs1181241617, gnomAD rs1181241617, REVEL 0.15, MetaLR 0.15
- T45T (p.Thr45Thr), gnomAD 7-74777329-C-A, CADD 0.05
- T45P (p.Thr45Pro), rs1340497044, gnomAD 7-74778352-A-C, CADD 4.44, SIFT 0.05
- E46D (p.Glu46Asp), TOPMed rs1252865340, gnomAD rs1252865340
- E46K (p.Glu46Lys), rs1554413145, TOPMed rs1554413145, gnomAD rs1554413145, REVEL 0.34, MetaLR 0.35, Variant assessed as somatic; moderate impact.
- E46Q (p.Glu46Gln), TOPMed rs1554413145, gnomAD rs1554413145, MetaLR 0.35, MetaSVM -0.30
- E46* (p.Glu46Ter), gnomAD 7-74777330-G-T, CADD 35.00
- E46E (p.Glu46Glu), rs1252865340, gnomAD 7-74777332-G-A, CADD 4.88
- I47F (p.Ile47Phe), Ensembl rs1796488991, MetaLR 0.15, MetaSVM -0.95
- I47N (p.Ile47Asn), rs782558908, gnomAD 7-74778362-T-A, CADD 3.45, SIFT 0.01
- I47I (p.Ile47Ile), gnomAD 7-74778363-C-T, CADD 2.48
- Y48C (p.Tyr48Cys), ESP rs368948045, gnomAD rs368948045, REVEL 0.52, MetaLR 0.57
- Y48F (p.Tyr48Phe), ESP rs368948045, gnomAD rs368948045, REVEL 0.22, MetaLR 0.32
- Y48* (p.Tyr48Ter), gnomAD 7-74777337-AC-A, CADD 23.30
- Y48Y (p.Tyr48Tyr), rs782597081, gnomAD 7-74777338-C-T, CADD 5.88
- E49K (p.Glu49Lys), NCI-TCGA Cosmic COSV5687, REVEL 0.28, MetaLR 0.28, Variant assessed as somatic; moderate impact.
- E49* (p.Glu49Ter), gnomAD 7-74777339-G-T, CADD 35.00
- E49A (p.Glu49Ala), gnomAD 7-74777340-A-C, REVEL 0.26, MetaLR 0.44
- F50I (p.Phe50Ile), gnomAD 7-74777342-T-A, REVEL 0.42, MetaLR 0.46
- F50V (p.Phe50Val), gnomAD 7-74777342-T-G, REVEL 0.41, MetaLR 0.46
- F50F (p.Phe50Phe), rs1796489210, gnomAD 7-74777344-C-T, CADD 8.70
- F50L (p.Phe50Leu), gnomAD 7-74777344-C-A, REVEL 0.17, MetaLR 0.13
- H51P (p.His51Pro), ExAC rs782495977, TOPMed rs782495977, gnomAD rs782495977, REVEL 0.72, MetaLR 0.53
- H51Q (p.His51Gln), NCI-TCGA Cosmic COSV5687, Variant assessed as somatic; moderate impact.
- H51R (p.His51Arg), ExAC rs782495977, TOPMed rs782495977, gnomAD rs782495977, MetaLR 0.53, MetaSVM 0.25
- H51Y (p.His51Tyr), ExAC rs781835731, TOPMed rs781835731, gnomAD rs781835731, REVEL 0.69, MetaLR 0.56
- H51H (p.His51His), rs1353672234, gnomAD 7-74777347-T-C, CADD 3.91
- K52Q (p.Lys52Gln), rs1584369793, gnomAD 7-74778382-A-C, CADD 4.86, SIFT 0.09
- K52K (p.Lys52Lys), gnomAD 7-74779084-A-G, CADD 20.90
- T53I (p.Thr53Ile), TOPMed rs1235799901, gnomAD rs1235799901, REVEL 0.07, MetaLR 0.10
- T53S (p.Thr53Ser), TOPMed rs1235799901, gnomAD rs1235799901, MetaLR 0.04, MetaSVM -1.03
- T53N (p.Thr53Asn), gnomAD 7-74779086-C-A, REVEL 0.11, MetaLR 0.10
- T53T (p.Thr53Thr), gnomAD 7-74779087-C-A, CADD 8.08
- L54V (p.Leu54Val), Ensembl rs1197399867, CADD 4.74, SIFT 0.31
- L54I (p.Leu54Ile), gnomAD 7-74778364-C-A, CADD 1.88, SIFT 0.12
- L54F (p.Leu54Phe), gnomAD 7-74778364-C-T, CADD 2.42, SIFT 0.11
- L54R (p.Leu54Arg), gnomAD 7-74778365-T-G, CADD 3.46, SIFT 0.08
- L54H (p.Leu54His), gnomAD 7-74778365-T-A, CADD 3.49, SIFT 0.04
- L54L (p.Leu54Leu), rs1796513392, gnomAD 7-74778387-G-A, CADD 3.58
- L54* (p.Leu54Ter), gnomAD 7-74779089-T-G, CADD 35.00
- K55R (p.Lys55Arg), gnomAD rs1554413392, MetaLR 0.28, MetaSVM -0.50
- E56D (p.Glu56Asp), gnomAD rs1451704941, REVEL 0.09, MetaLR 0.08
- E56K (p.Glu56Lys), gnomAD 7-74779093-AG-A, CADD 33.00
- M57T (p.Met57Thr), Ensembl rs1796532372, REVEL 0.21, MetaLR 0.14
- F58Y (p.Phe58Tyr), 1000Genomes rs587716514, ExAC rs587716514, gnomAD rs587716514, REVEL 0.66, MetaLR 0.52, Uncertain significance, Inborn genetic diseases
- F58L (p.Phe58Leu), gnomAD 7-74779102-C-A, REVEL 0.39, MetaLR 0.27
- F58F (p.Phe58Phe), rs1554413396, gnomAD 7-74779102-C-T, CADD 5.59
- P59H (p.Pro59His), NCI-TCGA Cosmic COSV9919, Variant assessed as somatic; moderate impact.
- P59L (p.Pro59Leu), NCI-TCGA Cosmic COSV9919, MetaLR 0.64, MetaSVM 0.41, Variant assessed as somatic; moderate impact.
- P59P (p.Pro59Pro), rs587722945, gnomAD 7-74778369-G-A, CADD 0.76
- P59R (p.Pro59Arg), gnomAD 7-74778371-C-G, CADD 0.90, SIFT 0.07
- P59S (p.Pro59Ser), rs1413615945, gnomAD 7-74778376-C-T, CADD 3.94, SIFT 0.40
- P59T (p.Pro59Thr), gnomAD 7-74778379-C-A, CADD 2.84, SIFT 0.18
- I60T (p.Ile60Thr), gnomAD rs1207998330, REVEL 0.41, MetaLR 0.45
- I60V (p.Ile60Val), gnomAD 7-74779106-A-G, REVEL 0.13, MetaLR 0.18
- I60M (p.Ile60Met), gnomAD 7-74779108-T-G, REVEL 0.34, MetaLR 0.35
- E61K (p.Glu61Lys), gnomAD rs1554413398, MetaLR 0.61, MetaSVM 0.49
- E61G (p.Glu61Gly), gnomAD 7-74779110-A-G, REVEL 0.52, MetaLR 0.45
- E61E (p.Glu61Glu), rs1355359543, gnomAD 7-74779111-G-A, CADD 9.33
- A62V (p.Ala62Val), Ensembl rs1796532760, REVEL 0.40, MetaLR 0.52
- A62S (p.Ala62Ser), gnomAD 7-74779112-G-T, REVEL 0.08, MetaLR 0.19
- A62E (p.Ala62Glu), gnomAD 7-74779113-C-A, REVEL 0.31, MetaLR 0.37
- A62A (p.Ala62Ala), rs1309796480, gnomAD 7-74779114-A-G, CADD 1.13
- G63V (p.Gly63Val), TOPMed rs1242540658, REVEL 0.59, MetaLR 0.59
- G63* (p.Gly63Ter), gnomAD 7-74778391-G-T, CADD 4.02
- G63R (p.Gly63Arg), gnomAD 7-74779115-G-A, REVEL 0.66, MetaLR 0.62
- G63W (p.Gly63Trp), gnomAD 7-74779115-G-T, REVEL 0.69, MetaLR 0.62
- G63G (p.Gly63Gly), gnomAD 7-74779117-G-C, CADD 4.24
- A64G (p.Ala64Gly), gnomAD rs1375017077, MetaLR 0.12, MetaSVM -1.02, Uncertain significance
- A64V (p.Ala64Val), rs1375017077, gnomAD rs1375017077, REVEL 0.17, MetaLR 0.09, Uncertain significance, Inborn genetic diseases
- A64T (p.Ala64Thr), gnomAD 7-74779118-G-A, REVEL 0.09, MetaLR 0.13
- A64E (p.Ala64Glu), gnomAD 7-74779119-C-A, REVEL 0.17, MetaLR 0.07
- A64A (p.Ala64Ala), rs1308832999, gnomAD 7-74779120-G-A, CADD 6.96
- N66D (p.Asn66Asp), gnomAD rs1554413401, REVEL 0.13, MetaLR 0.07
- N66K (p.Asn66Lys), TOPMed rs1554413403, gnomAD rs1554413403, REVEL 0.10, MetaLR 0.10
- N66S (p.Asn66Ser), 1000Genomes rs1437235552, gnomAD rs1437235552, REVEL 0.10, MetaLR 0.08
- N66Y (p.Asn66Tyr), gnomAD 7-74779124-A-T, REVEL 0.18, MetaLR 0.18
- N66I (p.Asn66Ile), gnomAD 7-74779125-A-T, REVEL 0.17, MetaLR 0.16
- N66N (p.Asn66Asn), rs1554413403, gnomAD 7-74779126-T-C, CADD 6.85
- P67L (p.Pro67Leu), gnomAD rs1351691379, REVEL 0.09, MetaLR 0.19
- P67Q (p.Pro67Gln), gnomAD 7-74779128-C-A, REVEL 0.09, MetaLR 0.23
- E68D (p.Glu68Asp), 1000Genomes rs782629025, ExAC rs782629025, gnomAD rs782629025, REVEL 0.10, MetaLR 0.21
- E68Q (p.Glu68Gln), gnomAD rs1554413404, REVEL 0.11, MetaLR 0.21
- E68K (p.Glu68Lys), gnomAD 7-74779130-G-A, REVEL 0.12, MetaLR 0.09
- E68E (p.Glu68Glu), rs782629025, gnomAD 7-74779132-G-A, CADD 7.48
- N69D (p.Asn69Asp), Ensembl rs1796533443, MetaLR 0.03, MetaSVM -1.02
- N69K (p.Asn69Lys), gnomAD 7-74779135-C-G, REVEL 0.11, MetaLR 0.06
- N69N (p.Asn69Asn), rs782242537, gnomAD 7-74779135-C-T, CADD 10.90
- R70M (p.Arg70Met), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
Public NCF1 analysis runs
- NCF1 analysis run — NCF1 (611 variants) — completed 2026-08-22